Molecular biology for patent strategy, due diligence, and public science.

I am a molecular biologist with deep expertise in CRISPR/Cas9 gene editing, nanotechnology-mediated delivery systems, and plant genomics. My PhD work focused on targeted genome modification, with publications in Nature Nanotechnology and ACS Nano, and I am a co-inventor on U.S. Patent 11,186,845 covering plant transformation methods.

Today I run Priori Intelligence, a consulting firm that provides AI-accelerated biotech patent landscape analysis and scientific due diligence. I am also preparing for the patent bar and pursuing a JD with an intellectual property focus, connecting bench science to the legal frameworks that protect it.

I also publish as @drgregshow, reaching millions through science debates, explainers, and public conversations. Through SAFE, I work on civic engagement through science literacy and evidence-based policy advocacy.